Related Experiment Video

Updated: Sep 26, 2026

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid
06:21

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid

Published on: April 7, 2023

Repeated hypoglycemia and cognitive decline. A case report

A Akyol1, N Kiylioglu, O Bolukbasi

  • 1Department of Neurology, Medical Faculty, Adnan Menderes University, 09100 Aydin, TURKEY. aakyol59@hotmail.com

Neuro Endocrinology Letters
|May 14, 2003
PubMed
Abstract

Insights

Severe hypoglycemia in a young type 1 diabetes patient caused significant cognitive decline and brain atrophy. Repeated severe hypoglycemic attacks were linked to memory processing deficits and global cerebral atrophy, incompatible with his age.

Area of Science:

  • Neuroscience
  • Endocrinology
  • Diabetology

Background:

  • Diabetes mellitus (DM) is a prevalent condition associated with microvascular complications.
  • Intensive therapy in type 1 DM can prevent long-term complications, but severe hypoglycemia poses a significant threat.
  • Hypoglycemia can potentially impair cognitive function, particularly in brain regions like the hippocampus.

Observation:

  • A young patient with type 1 DM presented with a severe cognitive defect.
  • The patient had a history of numerous severe hypoglycemic and hyperglycemic attacks, as well as seizures.
  • Neuroradiologic findings revealed global cerebral atrophy disproportionate to the patient's age.

Findings:

  • Brain perfusion studies (SPECT) indicated severe perfusion defects in the superior temporal region and frontal cingulate gyrus.
  • These affected brain regions are critical for memory processing.
  • The observed cognitive deficits and cerebral atrophy were strongly correlated with recurrent severe hypoglycemic episodes.

Implications:

  • Repeated severe hypoglycemia can lead to significant and lasting cognitive impairment in young individuals with type 1 DM.
  • This case highlights the critical need for stringent blood glucose control to prevent neurological damage.
  • Further research is warranted to understand the long-term neurocognitive consequences of severe hypoglycemia in diabetic patients.

More Related Videos

Alternate Immersion in Glucose to Produce Prolonged Hyperglycemia in Zebrafish05:49

Alternate Immersion in Glucose to Produce Prolonged Hyperglycemia in Zebrafish

Published on: May 5, 2021

Related Concept Videos

Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...